0
Article ? AI-assigned paper type based on the abstract. Classification may not be perfect — flag errors using the feedback button. Tier 2 ? Original research — experimental, observational, or case-control study. Direct primary evidence. Environmental Sources Human Health Effects Reproductive & Development Sign in to save

ERS International Congress 2022: highlights from the Basic and Translational Science Assembly

ERJ Open Research 2023 7 citations ? Citation count from OpenAlex, updated daily. May differ slightly from the publisher's own count. Score: 50 ? 0–100 AI score estimating relevance to the microplastics field. Papers below 30 are filtered from public browse.
Catherine M. Greene, Sara Cuevas Ocaña, Matthew Loxham, Natalia El-Merhie, Niki Ubags Merian E. Kuipers, Mareike Lehmann, Sara Rolandsson Enes, Carola Voss, Irene H. Heijink, Lareb S. N. Dean, Matthew Loxham, Matthew Loxham, Irene H. Heijink, Agnes W. Boots, Suzanne M. Cloonan, Catherine M. Greene, Irene H. Heijink, Audrey Joannes, Arnaud Mailleux, Nahal Mansouri, Niki L. Reynaert, Anne M. van der Does, Darcy E. Wagner, Niki Ubags

Summary

This review highlights key findings from the 2022 European Respiratory Society Congress on how climate change, air pollution, microplastics, and early-life events affect respiratory health, alongside advances in the Human Lung Cell Atlas, cell death pathways in lung disease, and novel asthma therapies.

In this review, the Basic and Translational Science Assembly of the European Respiratory Society provides an overview of the 2022 International Congress highlights. We discuss the consequences of respiratory events from birth until old age regarding climate change related alterations in air quality due to pollution caused by increased ozone, pollen, wildfires and fuel combustion as well as the increasing presence of microplastic and microfibres. Early life events such as the effect of hyperoxia in the context of bronchopulmonary dysplasia and crucial effects of the intrauterine environment in the context of pre-eclampsia were discussed. The Human Lung Cell Atlas (HLCA) was put forward as a new point of reference for healthy human lungs. The combination of single-cell RNA sequencing and spatial data in the HLCA has enabled the discovery of new cell types/states and niches, and served as a platform that facilitates further investigation of mechanistic perturbations. The role of cell death modalities in regulating the onset and progression of chronic lung diseases and its potential as a therapeutic target was also discussed. Translational studies identified novel therapeutic targets and immunoregulatory mechanisms in asthma. Lastly, it was highlighted that the choice of regenerative therapy depends on disease severity, ranging from transplantation to cell therapies and regenerative pharmacology.

Sign in to start a discussion.

Share this paper